After the Nvidelity comes the Huangover. Jensen Huang joins long list who confused boardroom and bedroom
What’s going to happen to the tech industry in 2016? Fewer IPOs, compressed unicorn valuation and slowing M&A activity December 8, 2015 The year 2015 was packed with fintech unicorns, blockchain hype and tech bubble fears – but what’s in store for the tech industry in 2016? M&A advisers Magister Advisors have peered into their crystal ball and offered their top predictions. The TL;DR version? Expect 2015’s “reality distortion field” to dissolve next year. Gulp. 1. Don’t hold your breath for [...]
Record M&A boom could lead to $2 trillion in cost savings after $4.9 trillion of deals in two years December 1, 2015 The global boom in M&A could result in nearly $2 trillion (£1.33 trillion) in savings for companies, according to data from Deloitte. Since January 2014, $4.9 trillion-worth of corporate deals have been announced, and if all the cost-savings promised are delivered, companies could add between $1.5 and $1.9 trillion to their value, making the annualised savings worth around three to [...]
These are the biggest mergers that have made 2015 a record-breaking year for global M&A, worth $4.2 trillion November 24, 2015 Yesterday's $160bn merger between Viagra-maker and Allergan, which makes Botox, helped the value of 2015 deals to grow to $4.2 trillion (£2.8 trillion) – an all-time record high. But Pfizer's merger is just one of many eye-watering deals that have made 2015 the year of the mega-deal. In fact, five deals from 2015 make it in to the top 20 deals [...]
Fever pitch: Pfizer and Allergan $160bn pharma mega-deal makes 2015 a record-smashing year for global M&A November 23, 2015 Global mergers and acquisitions have soared to an all-time high, pushed into the record books by the largest pharmaceuticals deal in history. The total value of worldwide M&A hit $4.2 trillion (£2.8 trillion), according to figures from Thomson Reuters, overtaking 2007’s previous record high. Pfizer’s $160bn merger with Ireland-based Allergan became the latest mega-deal to be confirmed [...]
What slowdown? JP Morgan says Asian companies like Tata and Nikkei will drive global M&A boom in the quest for long-term growth November 19, 2015 The good times look here to stay for the global M&A market, as 88 per cent of Asian companies say mergers and acquisitions are vital to their growth strategy, according to a market report from JP Morgan. Over the last 12 months, deal volumes in the Asia Pacific region have grown 61 per cent $1.05 [...]
Visa, King and BG Group deals push global M&A over $4 trillion mark for the first time in November November 4, 2015 Visa's $23.3bn (£15.2bn) offer for Visa Europe on Monday tipped the volume of global mergers and acquisitions over the $4 trillion mark for 2015 so far – the highest it's ever hit by this point in the year. Research by Dealogic showed Visa, along with a gaggle of acquisitive tech and pharma companies, pushed global volumes 38 per cent higher [...]
M&A work boosts Huntsworth income October 19, 2005 PR group Huntsworth has reported that income in its core public relations and healthcare division has risen above last year’s. The company, which owns investor and financial PR companies Citigate Dewe Rogerson and Hudson Sandler, saw like-for-like income rise 3.7 per cent in the six months to 30 June. Rising stock markets and the increased [...]
Jurys backing offer October 13, 2005 The board of the Irish hotels group Jurys has recommended a bid led by the daughters of the late founder P.V Doyle to take the company private. The hotel group board announced yesterday that it had reached terms with JDH Acquisitions, a group that has the support of 40 per cent of Jurys shareholders. A [...]